Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-α levels in non-obese women with polycystic ovary syndrome
Authors:
- Young Sik ChoiYCYoung Sik Choi
- Hyo In YangHYHyo In Yang
- SiHyun ChoSCSiHyun Cho
- Ji Ann JungJJJi Ann Jung
- Young Eun JeonYJYoung Eun Jeon
- Hye Yeon KimHKHye Yeon Kim
- Seok Kyo SeoSSSeok Kyo Seo
- Byung Seok LeeBLByung Seok Lee
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Science and Technology (2010-0003065)
- National Research Foundation of Korea
This publication has 46 references indexed in Scilit:
- Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypesFertility and Sterility, 2010
- Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndromeInternational Journal of Gynecology & Obstetrics, 2009
- Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndromeEuropean Journal of Endocrinology, 2009
- Evidence of proatherogenic inflammation in polycystic ovary syndromeMetabolism, 2009
- Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysisHuman Reproduction Update, 2009
- The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial functionFertility and Sterility, 2009
- Plasma Apelin is Lower in Patients with Elevated LDL-CholesterolExperimental and Clinical Endocrinology & Diabetes, 2007
- Endothelial Function Varies According to Insulin Resistance Disease TypeDiabetes Care, 2007
- Regulatory Roles for APJ, a Seven-transmembrane Receptor Related to Angiotensin-type 1 Receptor in Blood Pressure in VivoJournal of Biological Chemistry, 2004
- Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.Journal of Clinical Investigation, 1994